| Year |
Citation |
Score |
| 2020 |
Cai Z, Aguilera F, Ramdas B, Daulatabad SV, Srivastava R, Kotzin JJ, Carroll M, Wertheim G, Williams A, Janga SC, Zhang C, Henao-Mejia J, Kapur R. Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells. Cell Reports. 31: 107816. PMID 32579941 DOI: 10.1016/J.Celrep.2020.107816 |
0.348 |
|
| 2019 |
Cai Z, Ramdas B, Kotzin J, Carroll MP, Wertheim G, Williams A, Henao-Mejia J, Kapur R. Lncrna Morrbid Regulates Myeloid Cell Survival of AML Driven By a Combination of FLT3ITD and Epigenetic Mutations Blood. 134: 915-915. DOI: 10.1182/Blood-2019-130653 |
0.372 |
|
| 2019 |
Hurtz C, Wertheim G, Bhansali RS, Lehman A, Jeschke G, Crispino JD, Besson T, Tasian SK, Carroll M. DYRK1A Is Regulated By Oncogenic KMT2A and Required for Survival of KMT2A-Rearranged Acute Lymphoblastic Leukemia Blood. 134: 2742-2742. DOI: 10.1182/Blood-2019-123475 |
0.36 |
|
| 2018 |
Krevvata M, Shan X, Zhou C, Dos Santos C, Habineza Ndikuyeze G, Secreto A, Glover J, Trotman W, Brake-Silla G, Nunez-Cruz S, Wertheim G, Ra HJ, Griffiths E, Papachristou C, Danet-Desnoyers G, et al. Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells. Haematologica. PMID 29545344 DOI: 10.3324/Haematol.2017.183202 |
0.325 |
|
| 2018 |
Oberley MJ, Wertheim G, Raikar SS, Malvar J, Sposto R, Punia JN, Rabin KR, Seif AE, Schore RJ, Luca DC, Guinipero T, Woods WG, O'Gorman MR, Orgel E. Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study Blood. 132: 4080-4080. DOI: 10.1182/Blood-2018-99-117377 |
0.338 |
|
| 2018 |
Cotner CE, Modi M, Wertheim G, Paessler M, Tasian SK, Luo M, Pillai V. Immunophenotypic and Genetic Overlap between JMML and CMML Blood. 132: 1803-1803. DOI: 10.1182/Blood-2018-99-116730 |
0.311 |
|
| 2018 |
Oberley MJ, Raikar SS, Malvar J, Wertheim G, Seif AE, Guinipero T, Sposto R, Rabin KR, Punia JN, Schore RJ, Luca DC, Woods WG, O'Gorman MR, Orgel E. Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study Blood. 132: 558-558. DOI: 10.1182/Blood-2018-99-113606 |
0.338 |
|
| 2017 |
Lalonde E, Wertheim G, Li MM. Clinical Impact of Genomic Information in Pediatric Leukemia. Frontiers in Pediatrics. 5: 263. PMID 29312903 DOI: 10.3389/Fped.2017.00263 |
0.314 |
|
| 2017 |
Wertheim GBW, Luskin MR, Carroll M, Master SR. Microsphere-Based Assessment of DNA Methylation for AML Prognosis. Methods in Molecular Biology (Clifton, N.J.). 1633: 125-136. PMID 28735484 DOI: 10.1007/978-1-4939-7142-8_8 |
0.6 |
|
| 2016 |
DiNardo CD, Luskin MR, Carroll M, Smith C, Harrison J, Pierce S, Kornblau S, Konopleva M, Kadia T, Kantarjian H, Wertheim GB, Master SR. Validation of a Clinical Assay of Multi-Locus DNA Methylation for Prognosis of Newly Diagnosed AML. American Journal of Hematology. PMID 27804182 DOI: 10.1002/Ajh.24597 |
0.584 |
|
| 2016 |
Luskin MR, Gimotty PA, Smith C, Loren AW, Figueroa ME, Harrison J, Sun Z, Tallman MS, Paietta EM, Litzow MR, Melnick AM, Levine RL, Fernandez HF, Luger SM, Carroll M, ... ... Wertheim GB, et al. A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia. Jci Insight. 1. PMID 27446991 DOI: 10.1172/Jci.Insight.87323 |
0.593 |
|
| 2016 |
Teachey DT, Lacey SF, Shaw PA, Melenhorst JJ, Maude SL, Frey N, Pequignot E, Gonzalez VE, Chen F, Finklestein J, Barrett DM, Weiss SL, Fitzgerald JC, Berg RA, Aplenc R, ... ... Wertheim G, et al. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T cell Therapy for Acute Lymphoblastic Leukemia. Cancer Discovery. PMID 27076371 DOI: 10.1158/2159-8290.Cd-16-0040 |
0.304 |
|
| 2016 |
Hurtz C, Tasian SK, Wertheim G, Astles R, Zebrowski A, Perl AE, Carroll M. Adaptive Reactivation of Signaling Pathways As a Novel Mechanism of Resistance to JAK Inhibitors in Ph-like ALL Blood. 128: 755-755. DOI: 10.1182/Blood.V128.22.755.755 |
0.304 |
|
| 2015 |
Freedman JL, Desai AV, Bailey LC, Aplenc R, Burnworth B, Zehentner BK, Teachey DT, Wertheim G. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients. Pediatric Blood & Cancer. PMID 26274939 DOI: 10.1002/Pbc.25694 |
0.321 |
|
| 2015 |
Wertheim GB, Smith C, Luskin M, Rager A, Figueroa ME, Carroll M, Master SR. Validation of DNA methylation to predict outcome in acute myeloid leukemia by use of xMELP. Clinical Chemistry. 61: 249-58. PMID 25348669 DOI: 10.1373/Clinchem.2014.229781 |
0.591 |
|
| 2015 |
Luskin MR, Gimotty P, Smith C, Loren A, Figueroa M, Harrison J, Sun Z, Tallman MS, Paietta E, Litzow MR, Levine RL, Fernandez HF, Luger S, Carroll M, Master S, ... Wertheim G, et al. A Clinical Measure of DNA Methylation Predicts Outcome in De Novo AML Blood. 126: 2591-2591. DOI: 10.1182/Blood.V126.23.2591.2591 |
0.582 |
|
| 2014 |
Wertheim GB, Smith C, Figueroa ME, Kalos M, Bagg A, Carroll M, Master SR. Microsphere-based multiplex analysis of DNA methylation in acute myeloid leukemia. The Journal of Molecular Diagnostics : Jmd. 16: 207-15. PMID 24373919 DOI: 10.1016/J.Jmoldx.2013.10.010 |
0.583 |
|
| 2014 |
Raess PW, van de Geijn GJ, Njo TL, Klop B, Sukhachev D, Wertheim G, McAleer T, Master SR, Bagg A. Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters. American Journal of Hematology. 89: 369-74. PMID 24276948 DOI: 10.1002/Ajh.23643 |
0.575 |
|
| 2014 |
Luskin MR, Gimotty PA, Wertheim G, Smith C, Sehgal AR, Luger SM, Master SR, Loren AW, Carroll MP. A Measure of DNA Methylation for Predicting Outcome in De Novo AML Blood. 124: 2345-2345. DOI: 10.1182/Blood.V124.21.2345.2345 |
0.607 |
|
| 2014 |
Bhoj V, Milone MC, June CH, Porter D, Grupp SA, Melenhorst JJ, Lacey SF, Callahan C, Capobianchi J, Wertheim G, Mahnke Y. Humoral Immunity and Plasma Cell Changes in Patients Responding to CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T-Cell Adoptive Immunotherapy Blood. 124: 1110-1110. DOI: 10.1182/Blood.V124.21.1110.1110 |
0.309 |
|
| 2010 |
Paralkar VR, Xavier MF, Mato AR, Wertheim G, Weiss J, Arnoldi S, Algazy K, Goldstein SC, Nasta SD, Stadtmauer EA, Schuster SJ, Tsai D. Clinical Trial of a Multitarget EBV PCR Panel In Patients with EBV Positive Malignancies: Correlation of Peripheral Blood EBV Viral Load with Disease Activity Blood. 116: 5079-5079. DOI: 10.1182/Blood.V116.21.5079.5079 |
0.301 |
|
| 2009 |
Wertheim GB, Yang TW, Pan TC, Ramne A, Liu Z, Gardner HP, Dugan KD, Kristel P, Kreike B, van de Vijver MJ, Cardiff RD, Reynolds C, Chodosh LA. The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America. 106: 15855-60. PMID 19717424 DOI: 10.1073/Pnas.0906993106 |
0.66 |
|
| 2002 |
Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB, Chodosh LA. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 283-92. PMID 11874978 DOI: 10.1096/Fj.01-0551Com |
0.675 |
|
| 2000 |
Gardner HP, Belka GK, Wertheim GB, Hartman JL, Ha SI, Gimotty PA, Marquis ST, Chodosh LA. Developmental role of the SNF1-related kinase Hunk in pregnancy-induced changes in the mammary gland. Development (Cambridge, England). 127: 4493-509. PMID 11003847 |
0.51 |
|
| 2000 |
Gardner HP, Wertheim GB, Ha SI, Copeland NG, Gilbert DJ, Jenkins NA, Marquis ST, Chodosh LA. Cloning and characterization of Hunk, a novel mammalian SNF1-related protein kinase. Genomics. 63: 46-59. PMID 10662544 DOI: 10.1006/Geno.1999.6078 |
0.498 |
|
| Show low-probability matches. |